ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Lipid lowering agent: Nicotinic acid derivative
5-Metylpyrazinecarboxylic acid 4-oxide (WHO)
- Acipimoxum (Latin)
- Acipimox (German)
- Acipimox (French)
- Acipimox (Spanish)
- Acipimox (OS: DCF, BAN)
- K 9321 (IS)
Takeda Nederland, Netherlands
Dr. Fisher Farma, Netherlands; Euro Registratie, Netherlands; Farmitalia, Kuwait; Laboratorio Pfizer de Chile, Chile; Pfizer, Austria; Pfizer, Belgium; Pfizer, Denmark; Pfizer, United Kingdom; Pfizer, Hong Kong; Pfizer, Netherlands; Pfizer, New Zealand; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Pfizer Pharmaceuticals Ltd, China
- Olbetam 250mg
Pfizer, Hungary; Pfizer, Luxembourg; Pfizer PFE, Switzerland
- Si Li Meng
Di Ao Pharmaceutical Group, China
Lunan Pharmaceutical, China
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.